About Healx
Operator of an AI-powered, patient-inspired tech company intended to accelerate the discovery and development of treatments for rare diseases. The company's platform uses Artificial Intelligence to leverage the combination of algorithms to predict and de-risk novel connections in biomedical data and move the promising ones toward the clinic, enabling clinics to develop advanced treatment methods for rare disease remedies.
Company details
Funding
Total raised
$134M
Last stage
Series C
Investors
Founders
David Brown
Formerly global head of drug discovery at Roche. Co-inventor of Viagra. Has invented multiple drugs that reached market, generating over $40 billion in revenue.
Nick Sireau
Co-founder of Healx, focused on rare disease drug discovery.
Tim Guilliams
PhD in Biophysical Neuroscience from the University of Cambridge. Tech entrepreneur and social entrepreneur passionate about leveraging AI to accelerate treatments for rare diseases. Also Co-Founder and Chair of the Cambridge Rare Disease Network.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.